Analysis of domestic veterinary drug raw material market in the 18th week of 2026
Special note:
The 94th API China will be held in Shanghai from May 13th to 15th.
The 23rd China Animal Husbandry Expo will be held in Chengdu from May 18th to 20th.
Penicillin products have been performing weakly overall.
Amoxicillin and amoxicillin sodium. The market situation in the first week of May was generally stable, with significant differences in transaction prices across different brands and regions. For amoxicillin sodium, the market price ranged from 300 to 340, and the market trend remained stable in May.
Amoxicillin and clavulanate potassium, with a market price of 485, reached its lowest point in the same period over the past five years, and the market trend in May was weak.
Ampicillin and ampicillin sodium are in a relatively weak operational state, with a market price of 185; ampicillin sodium is priced between 280 and 325, and the market trend in May is downward.
Penicillin sodium, with a transaction price range of 105-115/billion, saw a month-on-month decrease of 0.3%, a narrowed decrease of 0.2 percentage points, and a year-on-year decrease of nearly 30%. It has been hovering at a low level for the past six months.
Penicillin potassium industrial salt has hit a new low in the past six months, with transaction prices ranging from 58 to 68 per billion. The month-on-month decrease is 0.4%, and the year-on-year decrease exceeds 40%. The average prices for the same period in the past five years from 2025 to 2021 were 116, 112, 144, 125, and 97, respectively.
Ceftiofur sodium and cefotiofur hydrochloride. Ceftiofur sodium is operating smoothly, with a market price of 840, which has decreased by over 10% compared to last week's market conditions. Cefotiofur hydrochloride has a price range of 750-860, and the average prices for the same period in the past three years from 2025 to 2023 were 1020, 970, and 1180 respectively.
Cefquinome sulfate, with a market price of 3920, has seen a month-on-month decrease of 0.5% and a year-on-year decrease of 18.9%. The average prices for the same period in the past five years from 2025 to 2021 were 4690, 5520, 6150, 6900, and 8350 respectively.
The overall performance of tetracycline and chloramphenicol products was relatively weak. In April, florfenicol experienced volatile adjustments, surging to the 170-line level before falling back, with a decrease of over 3%. Doxycycline hydrochloride decreased by over 5%, and oxytetracycline hydrochloride decreased by over 3%.
Fluoroquinolone has significant price variations across different regions and brands. The market transaction price is below the 170 line. As we enter the second quarter in May, the trading market remains stable overall. The prices for the same period in 2025 and 2024 were maintained around 190, while the average prices for the same period in 2023 and 2022 were 372 and 451, respectively.
Thiamphenicol, with a stable market situation.
As we enter May, the market for doxycycline hydrochloride continues to decline.
Oxytetracycline and oxytetracycline hydrochloride. Oxytetracycline, with a relatively weak performance, has seen a narrowed decline; oxytetracycline hydrochloride has been actively traded since May, with significant price differences across regions and brands, trading within a range of 95-105. The average prices for the same period over the past five years, from 2025 to 2021, are 95, 93, 96, 108, and 114, respectively.
Chlortetracycline hydrochloride, with a stable market situation.
The overall market for aminoglycoside products remains stable.
Neomycin sulfate has maintained a stable market trend, with a market price ranging from 145 to 155 per billion. The average prices for the same period in the past five years, from 2025 to 2022, were 159, 138, 138, 149, and 143 respectively. The market situation in May remained stable.
Spectinomycin dihydrochloride (dihydrate), with relatively strong performance, has a market price ranging from 550 to 565. The average prices from 2025 to May 2023 are as follows:
568, 500, 510.
Streptomycin sulfate, with a stable market situation.
Amprolium sulfate has a stable market situation, with little change compared to last week.
Kanamycin monosulfate, with a market transaction price of around 290/billion, saw a month-on-month decrease of 1.7%, while its year-on-year transaction price remained unchanged. The market situation in May was stable.
Amikacin sulfate, with a market price of 730, has shown a weakening trend in May.
Gentamicin sulfate, with a stable market situation.
Macrolide products are experiencing volatile adjustments, with attention being paid to the market changes in API China Shanghai in May.
Tylosin Tartrate has a stable market situation, with a market price around 270. The average prices in May for the past three years, from 2025 to 2023, were 248, 221, and 287 respectively.
Tilmicosin and tilmicosin phosphate. The market price of tilmicosin is 359; the market price of tilmicosin phosphate is 299, which is basically the same as last week's price, with a year-on-year decrease of 6.7%. The average prices from April to June last year were 306, 336, and 425 respectively.
Kitasamycin tartrate has been operating steadily in the market in May.
Tylvalosin tartrate, with a trading market price of 370-390, has shown a steady decline in the past five weeks, with a year-on-year decrease of 3.9%.
Tylosin, market price 5950.
Erythromycin thiocyanate has undergone market fluctuations and adjustments, with a market price around 480. The market trend in May is stable.
Colistin sulfate is highly sought after and actively traded, with a market price of around 115. The average market prices for the past three years, from 2025 to 2023, were 113, 109, and 97 respectively.
Tylosin fumarate has a stable market situation, with a market price of 259.
Lincomycin hydrochloride has maintained a stable market trend, with little change compared to last week.
Original article from Asia-Pacific Easy and Data Analysis Research Institute. Reproduction without permission is prohibited. All rights reserved. For reproduction and quotation, please contact the author and indicate the original source.
The overall market for quinolones remains stable.
Enrofloxacin and enrofloxacin hydrochloride. The market price is around 170, with a strong upward trend in May.
Ciprofloxacin lactate (hydrochloride), priced at 165, has maintained a stable market trend overall, showing a stability compared to the previous week's market. The year-on-year decrease is 10.2%. The average prices from 2025 to May 2023 are as follows:
179, 191, 212.
Sarafloxacin hydrochloride, with a stable market situation.
Mapofloxacin, with a market price of 2250, saw a month-on-month increase of 2.6% and a year-on-year decrease of 12.7%. The market trend in May was relatively strong.
The market for sulfa products is mainly stable.
Sulfamethoxazole (sodium) has a stable market, with transaction prices ranging from 199 to 230, which is basically the same as that of the same period last year.
Sulfamethoxazole (sodium) has a stable market situation, with a market price ranging from 235 to 245.
Sulfamethoxazole (sodium), market price 105-145.
Sulfadiazine (sodium) has a stable market situation, with a market price of 155. The average prices for the same period in 2025-2023 were 165, 158, and 201 respectively.
Sulfamethazine (sodium) has a market price of 100-110, which is stable compared to last week's market situation, with a year-on-year increase of 22.2%.
Sulfamethoxazole sodium, with a stable market situation.
Sulfamethoxazole and pyrimethamine sodium, with prices basically unchanged compared to last week, had average prices from 2025 to May 2023 as follows:
211, 227, 295.
Sulfamethoxazole sodium, with prices basically unchanged compared to last week, had average prices from 2025 to May 2023 as follows:
169, 143, 180.
"Dimethoxypyridine, with a relatively strong effect.".
Trimethoprim, trimethoprim lactate. Trimethoprim, market price 245; trimethoprim lactate, market price 190, unchanged from the same period in 2025 and 2021, but nearly three percentage points higher than the same period prices in 2024, 2023, and 2022. The average prices for the same period in the past five years from 2025 to 2021 were 191, 184, 188, 186, and 190 respectively. The market trend in May was weak.
The anti-parasitic products have been operating steadily overall. Albendazole, avermectin, and cyromazine have been in high demand, while metronidazole, dimetridazole, and levamisole hydrochloride have seen a decline in market demand.
Abendazole is in high demand, with active trading. Its market price ranges from 145 to 165, showing a month-on-month increase of 0.7%, which is consistent with the price from the same period last year. Transaction prices vary significantly depending on regions and brands. The market trend in May is stable with a slight upward trend.
Fenbendazole, consolidating with fluctuations.
Avermectin, with a stable market situation, has a market price of 650, and the market trend is upward in May.
Ivermectin, with relatively strong performance, has a market price of 800. The average prices for the same period in the past five years from 2025 to 2021 were 792, 846, 1090, 1460, and 1410 respectively.
Diclazuril, with a market price of 1070, has seen an increase compared to last week's market situation, with a year-on-year increase of 4.4%.
Taoqu Zhuli, with strong operational performance, has a market price of 870.
Levamisole hydrochloride, with fluctuating market adjustments.
Amprolium hydrochloride has a stable market situation, with a market transaction price of 320. The transaction price range in April was 329-315, and the market trend in May is slightly stronger.
Metronidazole, with a stable market situation, has a market price of around 80, which is basically unchanged from the price of last week. The average prices for the same period in 2025, 2022, and 2023 were 79, 78, and 85 respectively. The market trend in April is upward.
Demenidazole, with a market price of around 100, remains basically unchanged compared to last week's price. The average prices for the same period from 2025 to 2023 were 89, 99, and 147 respectively.
Praziquantel, with prices basically remaining unchanged compared to last week.
Cyromazine, with a market price of 115, has shown an upward trend in May.
In the first quarter, anti-parasitic products experienced a trend of fluctuation and adjustment, initially rising and then falling. The average prices of albendazole for January to March were 134, 135, and 155, respectively, with an increase of over 5% in early March. For metronidazole and dimetridazole, the market remained stable in January and February. However, prices surged in late February and early March, with metronidazole's market price ranging from 76 to 85 in March and dimetridazole's ranging from 105 to 115. By the end of March, prices corrected and declined.
All rights reserved by Asia-Pacific Easy and Data Analysis Research Institute for the original article. The market data analysis refers to the comprehensive price of bulk products.
The overall trend of antipyretic and analgesic products remains stable.
Flunixin meglumine, with a market price range of 360-380, has seen a month-on-month decrease of 0.9% and a year-on-year decrease of over 10%. The market trend in April is downward.
Analgin has a stable market situation.
Acetaminophen, with fluctuating market conditions, has seen high transaction prices but a lackluster trading market.
Aminopyrine, with a market price of 110, has seen an increase compared to last week's market situation, while remaining basically unchanged compared to the same period last year. The market price in the first quarter stabilized around 100.
Aminophylline, with a relatively strong effect, has a market price of 115.
Aspirin, with a market price of 22,300/ton.
Taurine, the market situation has cooled down and adjusted.
After a strong market surge in March, the market for Carbamazepine Calcium stabilized in April with small fluctuations, and then showed a weakening trend in May.
Acetylmequine, the market is experiencing consolidation with fluctuations.
Sodium camphor sulfonate, with a stable market situation.
Chlorpheniramine has been on a downward trend, experiencing a volatile rise in early March of the first quarter before falling back in April.
Sodium salicylate, with a rising market, is traded at a price of 26,700/ton.
Citric acid, the market continues to rise, with a market price of 4670/ton.
Sodium citrate, with a rising market trend, has a market price of 4690/ton.
Sodium carbonate, with a market price of 1900/ton.
Sodium bicarbonate, with a market price of 2000/ton.
Glucose, with a trading price of 3850-6400/ton, is performing strongly.
Jiayi powder, with a trading price of 2690-3280/ton, is operating with a strong trend.
Soluble starch, with a market price of 12,700/ton.
Beta-cyclodextrin, with a market price of 18,300/ton.
To learn more, please join the Asia-Pacific Yihe Data Analysis Research Institute as a member to stay informed about market changes in real time.
The overall trend of plant-based traditional Chinese medicinal materials remains stable.
Shuanghuanglian extract, 40-80.
Astragalus Polysaccharide Extract, 50-100.
Scutellaria baicalensis extract, 110-150.
Licorice extract, 60-100.
Honeysuckle extract, 60-100.
Honeysuckle, 55-120.
Coptis chinensis, 230-260.
Astragalus, 8-13.
Scutellaria, 16-25.
Yanhusuo, 43-55.
Chenpi, 10-13.
Hawthorn, 4-6.
Licorice, 10-14.
Dried ginger, 16-25.
Red flowers, 50-79.
Banlangen, 15-20.
The overall market for vitamin products has declined, with some products experiencing a decrease of over 3%.
VA, mixing material 100, water solubility 120, market has declined.
VB1, market stable, nitric acid 235, hydrochloric acid 280.
VB2, 98% purity priced at 278, 80% purity priced at 76.
VB6, with stable market conditions, has a market price of 110.
VB12 1%, market price 95, stable market condition.
VC, market quotation: feed grade 19-23, pharmaceutical grade 30, market stable.
VD3, market price for mixing is 140, water solubility is 160, and the market trend is slowing down.
VE, dressing 110, water solubility 120, stable with a slight decrease.
VK3, with a market price of 90, has seen a steady decline.
Calcium pantothenate, market price 67, market trend declining.
Nicotinamide, with a market price of 52, has a stable market situation.
Biotin 2%, market price 38.
Folic acid, with a market price of 335, has a stable market situation.
The above is the market data for veterinary drug ingredients released by Asia-Pacific Easy and Data Analysis Research Institute. Please leave a message for correction. To learn more information, please join as a member to grasp the dynamic changes in the market in real time.
